Can ancient ayurveda help cancer survivors? new study tests feasibility
NCT ID NCT06633926
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This study looks at whether two different health programs are practical and acceptable for women who have finished treatment for early-stage breast cancer. One program combines nutrition advice, lifestyle changes, yoga, and therapeutic touch (Ayurveda). The other is a self-guided online health education program. The goal is to see if survivors will join, stay in, and complete these programs, not to measure health outcomes. About 106 participants will be randomly assigned to one of the two programs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ayurveda intervention (nutrition education, lifestyle counseling, yoga, therapeutic touch) and health education program
- What this could lead to
- If successful, this could show that integrative approaches like Ayurveda are practical and acceptable for cancer survivors, paving the way for larger studies on their benefits.
- What could go wrong
- This is a small, early feasibility study, not designed to test if the interventions actually improve health. Results may not apply to all survivors, and participants might not find the programs acceptable or easy to follow.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
107 people
The number who actually took part.
- Started
-
Mar 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients 1. Age \>= 18 2. Able to understand study procedures and to comply with them for the entire length of the study. 3. Able to read, write, and understand English. 4. Ability of individual or legal guardian/representative to understand a verbal informed consent document, and the willingness to sign it. 5. Non-metastatic breast cancer patients who are between 1 and 36 months after completion of primary treatment (i.e., surgery, radiotherapy, chemotherapy) and are in a complete remission. 6. Participants should have received chemotherapy as part of their primary treatment. 7. Have an impaired quality of life (report a score of 5 or less on question 30 of the European Organisation for Research and Treatment of Cancer Quality of Life Cancer questionnaire (EORTC-QLQ-C30). "How would you rate your overall quality of life during the past week?" 8. Karnofsky Performance Status Score (KPS) \>=60 Ayurveda Practitioners 1\. Must be engaged as an Ayurvedic Intervention practitioner on the Renew study Exclusion Criteria: Patients 1. Contraindication to any study-related procedure or assessment. 2. Metastatic disease and receiving chemotherapy or radiotherapy at the time of study enrollment (participants with non-metastatic disease who are receiving anti-Her2 directed treatment alone in the adjuvant setting are eligible). 3. Participants are within 1 month after surgery for cancer, including breast reconstructive surgery but not including implant exchange. 4. Cancer surgery planned during the initial 6-month study period. 5. Been on adjuvant hormone therapy (for breast cancer) less than 2 months at the time of enrollment. 6. Received Ayurvedic treatment during the 3 months preceding enrollment. 7. If a participant reports severe anxiety or depression, has severe depression assessed by Patient Health Questionnaire (PHQ)-9 using a cut-off of 20 or higher, or severe anxiety assessed by the General Anxiety Disorder-7 (GAD-7) using a cut-off 15 or higher. 8. Current suicidal ideation. Ayurveda Practitioners 1\. None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anatomic stage I breast cancer ajcc V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kaiser Permanente Northwest (KPNW)
San Francisco, California, 94158, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
Vanderbilt Ingram Cancer Center
Nashville, Tennessee, 37212, United States
-
Zuckerberg San Francisco General
San Francisco, California, 94115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Weight-Loss drug shield breast cancer Survivors' hearts?
- Fasting during chemo: a new way to boost treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Digital therapy aims to tame the fear that haunts cancer survivors
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
- Can a vaccine train the immune system to hunt down hidden breast cancer cells?